Clinical Trial: Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis

Brief Summary:

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11

Detailed Summary:

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis

Sponsor: Seoul National University Hospital

Current Primary Outcome: remission induction at 30 weeks [ Time Frame: 30 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Seoul National University Hospital

Dates:
Date Received: May 18, 2015
Date Started: March 2015
Date Completion: April 2018
Last Updated: May 12, 2017
Last Verified: March 2017